TY  - JOUR
AU  - Navarro-Compán, Victoria
AU  - Navarro-Sarabia, Federico
PY  - 2011
DO  - 10.4137/CMT.S3781
SN  - 1179-559X
UR  - http://hdl.handle.net/10668/505
T2  - Clinical Medicine Insights: Therapeutics
AB  - Biological therapies have been a major advance in RA treatment. However, remission or response is not achieved in allpatients. Therefore, new drugs seem necessary. Most recent trials have focused in the development of three different groups of...
LA  - en
PB  - Libertas Academica
KW  - New targets
KW  - Monoclonal antibodies
KW  - Small molecules
KW  - Rheumatoid arthritis
KW  - Efficacy
KW  - Safety
KW  - Nuevos objetivos
KW  - Anticuerpos monoclonales
KW  - Moléculas pequeñas
KW  - Artritis reumatoide
KW  - Eficacia
KW  - Seguridad
KW  - Medical Subject Headings::Diseases::Musculoskeletal Diseases::Rheumatic Diseases::Arthritis, Rheumatoid
KW  - Medical Subject Headings::Chemicals and Drugs::Biological Factors::Intercellular Signaling Peptides and Proteins::Cytokines
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Complementary Therapies
TI  - Safety and Efficacy of the Newer Biological Therapeutics in the Treatment of Rheumatoid Arthritis
TY  - review article
ER  -